Giovanni Caforio

A Letter from Giovanni Caforio

The first year of our new company was truly a remarkable time in BMS history. I am proud of the significant accomplishments we made in the face of great adversity and change during the COVID-19 pandemic.

We created a leading biopharma company, a diversified company with leading medicines across oncology, hematology, immunology and cardiovascular. One with a broad and deep pipeline, and the financial flexibility to continue to invest in innovation. And one where the best people in the industry are committed to our mission to discover, develop and deliver innovative medicines to patients who need them.

Giovanni Caforio, M.D.
Board Chair and Chief Executive Officer

2020 Full-Year Revenues

highlights img1
highlights img2
highlights img3

*Includes revenues for products acquired as part of the Celgene acquisition from November 20, 2019, which was the date of the closing of the acquisition, through December 31, 2019 (excludes foreign currency revenue hedge gains and losses). **Includes revenues for products acquired as part of the Celgene acquisition for the current- and prior-year periods (excludes foreign currency revenue hedge gains and losses). See “Worldwide Pro Forma Revenue” in Quarterly Package of Financial Information for full year of 2020, which is available on bms.com/investors/financial-reporting/quarterly-results, for information on the revenue of the company and Celgene on a stand-alone basis for the prior-year period.

Patient Stories

“Researchers–and the work they do–matter more than they know.”

Winter Williams

“I am back to making plans and thinking about life.”

Holly Woods

“You are not alone, the world is not closed to you and your life is most certainly not over.”

Ben Johnson

“I felt like a pioneer; I’m hoping that many other people who have multiple myeloma will have the same success that I’ve had. My message for them is not to give up hope.”

Bill Herington

“As a researcher, I want to tell patients, ‘Thank you for being so patient. We are working hard to deliver this and other medicines to help transform lives.’ ”

Ryan Moslin
transforming image

“The best part has been regaining the freedom to do what I want.”

Hideko Kawajiri

Feature Stories